FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / J Vet Intern Med / Cannabidiol-induced cellular and matrix-associated responses...
Journal of veterinary internal medicine2026; 40(1); aalaf015; doi: 10.1093/jvimsj/aalaf015

Cannabidiol-induced cellular and matrix-associated responses in primary equine sarcoid cells.

Abstract: Sarcoids are locally invasive skin tumors in equids, associated with bovine papillomavirus. Objective: Address potential applications of cannabidiol (CBD) in veterinary medicine. We evaluated the response of equine sarcoid cells to CBD in vitro, focusing on viability, invasiveness, and matrix remodeling. Methods: Three primary sarcoid cell lines. Methods: Cells were treated with CBD (20, 6.75, 2.25, 0.75 μM) and incubated for 6, 24, 48, 72 hours. Cell viability, cytotoxicity, and apoptosis were assessed using the ApoTox-Glo Assay. Based on these results, further analyses were performed for selected conditions only, including the assessment of cell invasiveness using the ECMatrix™ Cell Invasion Assay and the quantification of matrix metalloproteinase (MMP)-1, -2, and -9 in the culture medium by ELISA. Results: Treatment with CBD affected cell viability, cytotoxicity, and apoptosis. At 48 hours, apoptosis (measured as caspase 3/7 activity) reached 49.5% and further increased to 75% at 72 hours. Marked cytotoxicity (>96%) and decreased viability were observed at 72 hours. Cannabidiol also significantly decreased MMP-1 concentration by 48.9% at 24 hours and MMP-2 concentrations by 84% at 6 hours. Concentrations of MMP-9 also decreased by 37.2% and 45.3% at 6 and 48 hours, respectively, after treatment with 20 μM. Despite observed decreases in cell invasiveness ranging from 34% to 59% after 24 hours, these changes were not significant. Conclusions: Our findings support further investigation of CBD's role in extracellular matrix modulation in sarcoid tumors.
© The Author(s) 2026. Published by Oxford University Press on behalf of the American College of Veterinary Internal Medicine.
Get Full Text
Publication Date: 2026-02-26 PubMed ID: 41742517PubMed Central: PMC12881954DOI: 10.1093/jvimsj/aalaf015Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This research investigates the effects of cannabidiol (CBD) on primary equine sarcoid cells, particularly regarding cell viability, invasiveness, apoptosis, and matrix remodeling.

Background

  • Equine sarcoids are locally invasive skin tumors found in horses and related species.
  • These tumors are linked to infection by bovine papillomavirus (BPV).
  • Current treatments for sarcoids are limited, and there is interest in exploring new therapeutic options.
  • Cannabidiol (CBD), a non-psychoactive component of cannabis, has shown potential in modulating cancer cell behavior in various models, making it a candidate for veterinary oncology research.

Objectives

  • The primary goal was to evaluate how CBD affects equine sarcoid cells in vitro, focusing on:
    • Cell viability and cytotoxicity
    • Apoptosis (programmed cell death)
    • Cell invasiveness
    • Extracellular matrix remodeling, particularly via matrix metalloproteinases (MMPs)
  • These endpoints were chosen due to their relevance in tumor progression and metastasis.

Methods

  • Three primary equine sarcoid cell lines were cultured and treated in vitro.
  • Cells were exposed to varying concentrations of CBD: 0.75, 2.25, 6.75, and 20 μM.
  • Incubation times included 6, 24, 48, and 72 hours to observe both short- and longer-term effects.
  • Cell viability, cytotoxicity, and apoptosis were measured using the ApoTox-Glo Assay, which combines viability indicators and caspase 3/7 activity (a marker of apoptosis).
  • Based on viability and apoptosis results, select conditions were further studied for:
    • Cell invasiveness, using the ECMatrix™ Cell Invasion Assay – which measures the ability of cells to migrate through a matrix barrier, simulating invasion.
    • Quantification of matrix metalloproteinases MMP-1, MMP-2, and MMP-9 in the culture medium by ELISA (enzyme-linked immunosorbent assay).
    • MMPs are enzymes involved in degradation and remodeling of the extracellular matrix, which plays a key role in tumor invasiveness.

Results

  • Apoptosis and Cytotoxicity:
    • There was a significant increase in apoptotic activity over time, with caspase 3/7 activity reaching 49.5% at 48 hours and rising further to 75% after 72 hours of treatment.
    • Cell cytotoxicity exceeded 96% at 72 hours, indicating substantial cell death.
    • Correspondingly, cell viability decreased significantly by 72 hours.
  • Matrix Metalloproteinase Levels:
    • MMP-1 concentration decreased by 48.9% at 24 hours post-treatment with CBD.
    • MMP-2 concentration was reduced by 84% as early as 6 hours post-treatment.
    • MMP-9 levels were decreased by 37.2% at 6 hours and 45.3% at 48 hours after treatment with 20 μM CBD.
  • Cell Invasiveness:
    • Although CBD treatment led to decreases in invasiveness ranging from 34% to 59% after 24 hours, these reductions were not statistically significant.

Conclusions and Implications

  • CBD exhibits cytotoxic and pro-apoptotic effects on equine sarcoid cells, significantly reducing their viability over time.
  • The observed downregulation of MMP-1, MMP-2, and MMP-9 suggests that CBD influences extracellular matrix remodeling mechanisms, which could impact tumor progression and invasion capacity.
  • Despite non-significant reductions in invasiveness in vitro, the trend suggests potential modulatory effects of CBD on tumor cell behavior related to metastasis.
  • Overall, the findings support further research into CBD as a possible therapeutic agent for managing equine sarcoids, particularly by targeting the tumor microenvironment and matrix interactions.
  • Further studies could explore optimization of dosing, mechanisms of action, and in vivo efficacy and safety.

Cite This Article

APA
Semik-Gurgul E, Ocłoń E, Zubel-Łojek J, Pędziwiatr R, Pawlina-Tyszko K. (2026). Cannabidiol-induced cellular and matrix-associated responses in primary equine sarcoid cells. J Vet Intern Med, 40(1), aalaf015. https://doi.org/10.1093/jvimsj/aalaf015

Publication

Journal of veterinary internal medicine
ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 40
Issue: 1
PII: aalaf015

Researcher Affiliations

Semik-Gurgul, Ewelina
  • Department of Animal Molecular Biology, National Research Institute of Animal Production, Krakowska 1 Street, 32-083 Balice, Poland.
Ocłoń, Ewa
  • Department of Infectious Diseases and Public Health Protection, University of Agriculture in Krakow, 1C Redzina Street, 30-248 Krakow, Poland.
  • Laboratory of Recombinant Proteins Production, Faculty of Veterinary Medicine University of Agriculture in Krakow, 1C Redzina Street, 30-248 Krakow, Poland.
Zubel-Łojek, Joanna
  • Department of Animal Physiology and Endocrinology, University of Agriculture in Krakow, Mickiewicza 24/28 Street, 30-059 Krakow, Poland.
Pędziwiatr, Rafał
  • Department of Diagnostics and Clinical Sciences, Faculty of Veterinary Medicine, University of Agriculture in Krakow, Mickiewicza 24/28 Street, 30-059 Kraków, Poland.
  • Equine Vet Clinic EQUI-VET, Proszowice 55A, 32-100 Stogniowice,  Poland.
Pawlina-Tyszko, Klaudia
  • Department of Animal Molecular Biology, National Research Institute of Animal Production, Krakowska 1 Street, 32-083 Balice, Poland.

MeSH Terms

  • Animals
  • Horses
  • Cannabidiol / pharmacology
  • Cannabidiol / therapeutic use
  • Horse Diseases / drug therapy
  • Horse Diseases / pathology
  • Apoptosis / drug effects
  • Cell Survival / drug effects
  • Skin Neoplasms / veterinary
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / pathology
  • Cell Line, Tumor
  • Sarcoidosis / veterinary
  • Sarcoidosis / drug therapy
  • Matrix Metalloproteinases / metabolism

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 44 references
  1. Melkamu S. A review on equine sarcoid: current techniques employed in sciences for diagnosis, prevention and control.. J Anim Res 2018;8:155-164.
    doi: 10.30954/2277-940X.06.2018.29google scholar: lookup
  2. Knottenbelt DC. A suggested clinical classification for the equine sarcoid.. Clin Tech Equine Prac 2005;4:278-295.
    doi: 10.1053/j.ctep.2005.10.008google scholar: lookup
  3. Funiciello B, Roccabianca P, Funiciello B, Roccabianca P. Equine sarcoid.. Equine Sci 2020.
  4. Nasir L, Campo MS. Bovine papillomaviruses: their role in the aetiology of cutaneous tumours of bovids and equids.. Vet Dermatol 2008;19:243-254.
    doi: 10.1111/j.1365-3164.2008.00683.xpubmed: 18927950google scholar: lookup
  5. Cochrane CA. Models in vivo of wound healing in the horse and the role of growth factors.. Vet Dermatol 1997;8:259-272.
    doi: 10.1111/j.1365-3164.1997.tb00272.xpubmed: 34645018google scholar: lookup
  6. Hanson RR. Complications of equine wound management and dermatologic surgery.. Vet Clin N Am Equine Pract 2008;24:663-696.
    doi: 10.1016/j.cveq.2008.10.005pubmed: 19203707google scholar: lookup
  7. Chakravarti B, Ravi J, Ganju RK, Chakravarti B, Ravi J, Ganju RK. Cannabinoids as therapeutic agents in cancer: current status and future implications.. Oncotarget 2014;5:5852-5872.
    doi: 10.18632/oncotarget.2233pmc: PMC4171598pubmed: 25115386google scholar: lookup
  8. Śledziński P, Nowak-Terpiłowska A, Zeyland J. Cannabinoids in medicine: cancer, immunity, and microbial diseases.. Int J Mol Sci 2021;22:1-22.
    doi: 10.3390/ijms22010263pmc: PMC7795897pubmed: 33383838google scholar: lookup
  9. Velasco G, Sánchez C, Guzmán M. Anticancer mechanisms of cannabinoids.. Curr Oncol 2016;23:23-32.
    doi: 10.3747/co.23.3080pmc: PMC4791144pubmed: 27022311google scholar: lookup
  10. Shrivastava A, Kuzontkoski PM, Groopman JE, Prasad A. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy.. Mol Cancer Ther 2011;10:1161-1172.
    doi: 10.1158/1535-7163.MCT-10-1100pubmed: 21566064google scholar: lookup
  11. McAllister SD, Murase R, Christian RT. Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.. Breast Cancer Res Treat 2011;129:37-47.
    doi: 10.1007/s10549-010-1177-4pmc: PMC3410650pubmed: 20859676google scholar: lookup
  12. Ramer R, Merkord J, Rohde H, Hinz B. Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1.. Biochem Pharmacol 2010;79:955-966.
    doi: 10.1016/j.bcp.2009.11.007pubmed: 19914218google scholar: lookup
  13. Ramer R, Rohde A, Merkord J, Rohde H, Hinz B. Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells.. Pharm Res 2010;27:2162-2174.
    doi: 10.1007/s11095-010-0219-2pubmed: 20668920google scholar: lookup
  14. Ligresti A, Moriello AS, Starowicz K. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.. J Pharmacol Exp Ther 2006;318:1375-1387.
    doi: 10.1124/jpet.106.105247pubmed: 16728591google scholar: lookup
  15. Massi P, Vaccani A, Bianchessi S, Costa B, Macchi P, Parolaro D. The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells.. Cell Mol Life Sci 2006;63:2057-2066.
    doi: 10.1007/s00018-006-6156-xpmc: PMC11136384pubmed: 16909207google scholar: lookup
  16. Massi P, Vaccani A, Ceruti S, Colombo A, Abbracchio MP, Parolaro D. Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines.. J Pharmacol Exp Ther 2004;308:838-845.
    doi: 10.1124/jpet.103.061002pubmed: 14617682google scholar: lookup
  17. Vaccani A, Massi P, Colombo A, Rubino T, Parolaro D. Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism.. Br J Pharmacol 2005;144:1032-1036.
    doi: 10.1038/sj.bjp.0706134pmc: PMC1576089pubmed: 15700028google scholar: lookup
  18. McKallip RJ, Jia W, Schlomer J, Warren JW, Nagarkatti PS, Nagarkatti M. Cannabidiol-induced apoptosis in human leukemia cells: a novel role of cannabidiol in the regulation of p22phox and Nox4 expression.. Mol Pharmacol 2006;70:897-908.
    doi: 10.1124/mol.106.023937pubmed: 16754784google scholar: lookup
  19. Marcu JP, Christian RT, Lau D. Cannabidiol enhances the inhibitory effects of Δ9- tetrahydrocannabinol on human glioblastoma cell proliferation and survival.. Mol Cancer Ther 2010;9:180-189.
    doi: 10.1158/1535-7163.MCT-09-0407pmc: PMC2806496pubmed: 20053780google scholar: lookup
  20. Semik-Gurgul E, Szmatoła T, Gurgul A. Methylome and transcriptome data integration reveals aberrantly regulated genes in equine sarcoids.. Biochimie 2023;213:100-113.
    doi: 10.1016/j.biochi.2023.05.008pubmed: 37211255google scholar: lookup
  21. Pawlina-Tyszko K, Semik-Gurgul E, Zabek T, Witkowski M. Methylation status of gene bodies of selected microRNA genes associated with neoplastic transformation in equine Sarcoids.. Cells 2022;11:1917.
    doi: 10.3390/cells11121917pmc: PMC9221590pubmed: 35741046google scholar: lookup
  22. Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis.. Nat Method 2012;9:671-675.
    doi: 10.1038/nmeth.2089pmc: PMC5554542pubmed: 22930834google scholar: lookup
  23. Kim NY, Mohan CD, Sethi G, Ahn KS. Cannabidiol activates MAPK pathway to induce apoptosis, paraptosis, and autophagy in colorectal cancer cells.. J Cell Biochem 2024;125:e30537.
    doi: 10.1002/jcb.30537pubmed: 38358093google scholar: lookup
  24. Huang CC, Chiu SC, Chao SC. Real-time monitoring of the cytotoxic and antimetastatic properties of cannabidiol in human oral squamous cell carcinoma cells using electric cell-substrate impedance sensing.. Int J Mol Sci 2022;23:15842.
    doi: 10.3390/ijms232415842pmc: PMC9785110pubmed: 36555480google scholar: lookup
  25. Wang F, Dezfouli AB, Khosravi M. Cannabidiol-induced crosstalk of apoptosis and macroautophagy in colorectal cancer cells involves p53 and Hsp70.. Cell Death Dis 2023;9:1-14.
    doi: 10.1038/s41420-023-01578-9pmc: PMC10403543pubmed: 37542074google scholar: lookup
  26. Ma L, Liu M, Liu C. Research progress on the mechanism of the antitumor effects of cannabidiol.. Molecules 2024;29:1943.
    doi: 10.3390/molecules29091943pmc: PMC11085351pubmed: 38731434google scholar: lookup
  27. Fu Z, Zhao PY, Yang XP. Cannabidiol regulates apoptosis and autophagy in inflammation and cancer: a review.. Front Pharmacol 2023;14:1094020.
    doi: 10.3389/fphar.2023.1094020pmc: PMC9899821pubmed: 36755953google scholar: lookup
  28. Sooda K, Allison SJ, Javid FA. Investigation of the cytotoxicity induced by cannabinoids on human ovarian carcinoma cells.. Pharmacol Res Perspect 2023;11:e01152.
    doi: 10.1002/prp2.1152pmc: PMC10723784pubmed: 38100640google scholar: lookup
  29. Gross C, Ramirez DA, McGrath S, Gustafson DL. Cannabidiol induces apoptosis and perturbs mitochondrial function in human and canine glioma cells.. Front Pharmacol 2021;12:725136.
    doi: 10.3389/fphar.2021.725136pmc: PMC8385407pubmed: 34456736google scholar: lookup
  30. Mokoena D, George BP, Abrahamse H. Cannabidiol combination enhances photodynamic therapy effects on MCF-7 breast cancer cells.. Cells 2024;13:187.
    doi: 10.3390/cells13020187pmc: PMC10814799pubmed: 38247877google scholar: lookup
  31. Olivas-Aguirre M, Torres-López L, Villatoro-Gómez K, Perez-Tapia SM, Pottosin I, Dobrovinskaya O. Cannabidiol on the path from the lab to the cancer patient: opportunities and challenges.. Pharmaceuticals 2022;15:366.
    doi: 10.3390/ph15030366pmc: PMC8951434pubmed: 35337163google scholar: lookup
  32. Podstawski P, Ropka-Molik K, Semik-Gurgul E. Assessment of BPV-1 mediated matrix metalloproteinase genes deregulation in the In vivo and In vitro models designed to explore molecular nature of equine Sarcoids.. Cells 2022;11:1268.
    doi: 10.3390/cells11081268pmc: PMC9025493pubmed: 35455948google scholar: lookup
  33. Yuan Z, Gault EA, Campo MS, Nasir L. Upregulation of equine matrix metalloproteinase 1 by bovine papillomavirus type 1 is through the transcription factor activator protein-1.. J Gen Virol 2011;92:2608-2619.
    doi: 10.1099/vir.0.033431-0pubmed: 21775582google scholar: lookup
  34. Yuan ZQ, Gobeil PAM, Campo MS, Nasir L. Equine sarcoid fibroblasts over-express matrix metalloproteinases and are invasive.. Virology 2010;396:143-151.
    doi: 10.1016/j.virol.2009.10.010pubmed: 19896685google scholar: lookup
  35. Yuan ZQ, Nicolson L, Marchetti B, Gault EA, Campo MS, Nasir L. Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts.. J Virol 2008;82:6481-6491.
    doi: 10.1128/JVI.00429-08pmc: PMC2447052pubmed: 18434409google scholar: lookup
  36. Mosseri S, Hetzel U, Hahn S. Equine sarcoid: In situ demonstration of matrix metalloproteinase expression.. Vet J 2014;202:279-285.
    doi: 10.1016/j.tvjl.2014.07.026pmc: PMC7128672pubmed: 25439440google scholar: lookup
  37. Martano M, Corteggio A, Restucci B, De Biase ME, Borzacchiello G, Maiolino P. Extracellular matrix remodeling in equine sarcoid: An immunohistochemical and molecular study.. BMC Vet Res 2016;12:24.
    doi: 10.1186/s12917-016-0648-1pmc: PMC4736642pubmed: 26838095google scholar: lookup
  38. Semik-Gurgul E. Molecular approaches to equine sarcoids.. Equine Vet J 2021;53:221-230.
    doi: 10.1111/evj.13322pubmed: 32654178google scholar: lookup
  39. Rawal SY, Dabbous MK, Tipton DA. Effect of cannabidiol on human gingival fibroblast extracellular matrix metabolism: MMP production and activity, and production of fibronectin and transforming growth factor β.. J Periodontal Res 2012;47:320-329.
    doi: 10.1111/j.1600-0765.2011.01435.xpubmed: 22092062google scholar: lookup
  40. Solinas M, Massi P, Cinquina V. Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect.. PLoS One 2013;8:e76918.
    doi: 10.1371/journal.pone.0076918pmc: PMC3804588pubmed: 24204703google scholar: lookup
  41. Elbaz M, Nasser MW, Ravi J. Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of cannabidiol in breast cancer.. Mol Oncol 2015;9:906-919.
    doi: 10.1016/j.molonc.2014.12.010pmc: PMC4387115pubmed: 25660577google scholar: lookup
  42. Whynot EG, Tomko AM, Dupré DJ. Anticancer properties of cannabidiol and Δ9-tetrahydrocannabinol and synergistic effects with gemcitabine and cisplatin in bladder cancer cell lines.. J Cannabis Res 2023;5:7.
    doi: 10.1186/s42238-023-00174-zpmc: PMC9985258pubmed: 36870996google scholar: lookup
  43. Gurgul A, Żurowski J, Szmatoła T. Cannabidiol (CBD) modulates the transcriptional profile of ethanol-exposed human dermal fibroblast cells.. J Appl Genet 2024;65:773-796.
    doi: 10.1007/s13353-024-00915-7pmc: PMC11561130pubmed: 39466591google scholar: lookup
  44. Tassaneesuwan N, Khongkow M, Jansrinual S, Khongkow P. Discovering the potential of cannabidiol for cosmeceutical development at the cellular level.. Pharmaceuticals 2025;18:202.
    doi: 10.3390/ph18020202pmc: PMC11859159pubmed: 40006016google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,030 horse owners like you who receive our email updates on horse health and nutrition.